Detalhe da pesquisa
1.
Secondary fracture and mortality risk with very high fracture risk osteoporosis and proximal femoral fracture.
J Bone Miner Metab;
42(2): 196-206, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38308695
2.
Comparison of the Efficacy of Zoledronate Acid or Denosumab After Switching from Romosozumab in Japanese Postmenopausal Patients.
Calcif Tissue Int;
112(6): 683-690, 2023 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37037949
3.
Secondary fracture rates and risk factors 1 year after a proximal femoral fracture under FLS.
J Bone Miner Metab;
41(4): 542-549, 2023 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37037921
4.
Short-term efficacy and safety of zoledronate acid or denosumab in Japanese patients with postmenopausal osteoporosis.
J Bone Miner Metab;
39(5): 824-832, 2021 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33821302
5.
Ten years change in post-fracture care for hip fracture patients.
J Bone Miner Metab;
38(2): 222-229, 2020 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31583538
6.
Pancreatic cancer initially presenting with a pseudocyst at the splenic flexure.
Pathol Int;
56(9): 558-62, 2006 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16930338